EP 1355661 A2 20031029 - TUMOR VACCINE
Title (en)
TUMOR VACCINE
Title (de)
TUMORVAKZINE
Title (fr)
VACCIN ANTITUMORAL
Publication
Application
Priority
- DE 0200380 W 20020130
- DE 10105421 A 20010131
Abstract (en)
[origin: WO02060476A2] The invention relates to a vaccine and to the production thereof for the treatment of patients suffering from defined tumor diseases. The inventive vaccine consists of tumor cells that were transfected ex vivo with expression constructs that code for certain cytokines. Immunostimulating oligodeoxyribonucleotides are used as the adjuvants.
IPC 1-7
IPC 8 full level
A61K 39/00 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61K 39/001136 (2018.08 - EP US); A61P 35/00 (2018.01 - EP); A61K 2039/5152 (2013.01 - EP US); A61K 2039/5156 (2013.01 - EP US); A61K 2039/55522 (2013.01 - EP); A61K 2039/55561 (2013.01 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02060476 A2 20020808; WO 02060476 A3 20030123; DE 10290185 D2 20040415; EP 1355661 A2 20031029
DOCDB simple family (application)
DE 0200380 W 20020130; DE 10290185 T 20020130; EP 02704624 A 20020130